Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Ibuprofen/Loratadine Fixed-dose Combination Versus the Fixed-dose Administration of Monotherapy as Symptomatic Treatment for Patients With the Common Cold

NCT06531707 is registered in ClinicalTrials.gov with Laboratorios Silanes S.A. de C.V. as lead sponsor.

NCT NCT06531707
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06531707 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Ibuprofen/Loratadine Fixed-dose Combination Versus the Fixed-dose Administration of Monotherapy as Symptomatic Treatment for Patients With the Common Cold
Lead sponsor
Laboratorios Silanes S.A. de C.V.
Phase
Phase 3
Overall status
Unknown status
Start date
May 20, 2024
Completion date
February 20, 2025
Enrollment
177 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

common cold